A 52-year-old male with type I diabetes since 16 years and chronic kidney disease since 10 years presented with pain and swelling of his right eye since 5 days associated with loss of vision since 3 days. On examination there was a blackish eschar in the right nasal cavity. Ophthalmologic examination revealed chemosis, proptosis and complete ophthalmoplegia of the right eye along with complete loss of vision ([Figure 1A](#F1){ref-type="fig"}). The patient underwent surgical debridement and orbital exenteration and was started on amphotericin B; however, his deteriorated and ultimately he succumbed to the illness 2 days later. The biopsy from the lesion was consistent with mucormycosis ([Figure 1B](#F1){ref-type="fig"}).

![Patient with right eye proptosis and ptosis **(A)**; Section show fungal organisms with broad angle branching hyphae suggestive of mucormycosis (HE, ×400) **(B)**](bet-7-088-g001){#F1}

About 70% of rhinocerebral cases are found in diabetic patients in ketoacidosis, others at risk are patients with solid organ or hematopoietic stem cell transplantation \[[@B1],[@B2]\]. The initial symptoms are of eye or facial pain and facial numbness.  If untreated, infection spreads to the orbit, resulting in ptosis, chemosis, and proptosis \[[@B2],[@B3]\]. Involvement of the cavernous sinus leads to cranial nerve III, IV, V, VI palsies and permanent blindness \[[@B3]\]. Diagnosing mucormycosis requires histopathological evidence of fungal invasion of the tissues and the extent of involvement can be assessed with CT or MRI scans \[[@B2]\]. The treatment is based on early identification, reversal of underlying pathology, surgical debridement of the infected tissue and starting antifungal therapy with amphotericin B \[[@B1]-[@B3]\]. The prognosis varies between 30 to 70% and worsens with the involvement of cavernous sinus \[[@B3]\].
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